XyloCor Therapeutics Funding & Investors
Malvern, PA
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
xylocor.comTotal Amount Raised: $107,100,000
XyloCor Therapeutics Funding Rounds
Series B
$67,500,000
Series B Investors
Jeito CapitalLumira VenturesLSPFountain Healthcare PartnersSeries A
$22,600,000
Series A Investors
Fountain Healthcare PartnersLumira VenturesSofinnova VenturesLSPLongwood FundSeries A
$17,000,000
Series A Investors
LSPSofinnova Ventures
Funding info provided by Diffbot.